Barclays’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.08M | Sell |
|
|||||
|
2024
Q1 | $3.97M | Sell |
|
|||||
|
2023
Q4 | $14.9M | Buy |
|
|||||
|
2023
Q3 | $3.19M | Buy |
|
|||||
|
2023
Q2 | $4.17M | Sell |
|
|||||
|
2023
Q1 | $14.7M | Buy |
|
|||||
|
2022
Q4 | $14.4M | Buy |
|
|||||
|
2022
Q3 | $2.76M | Buy |
|
|||||
|
2022
Q2 | $74K | Sell |
|
|||||
|
2022
Q1 | $239K | Buy |
|